Tag: Bulk drug substance

Prescription errors cost the U.S. healthcare system billions of dollars annually, underscoring the critical need for clarity in medical abbreviations. This is particularly true when decoding terms like **BDS in pharmacy**, which has multiple, distinct meanings depending on the context, from prescription directions to pharmaceutical manufacturing.

According to the FDA, poor compounding practices can result in contaminated drugs, leading to serious injury or death. A key **example of a high risk compounding** is the preparation of sterile injectables from non-sterile raw drug powders, a process that requires meticulous controls and terminal sterilization.